Reckitt Benckiser Group Management
Management criteria checks 0/4
Reckitt Benckiser Group's CEO is Kris Licht, appointed in Oct 2023, has a tenure of 1.58 years. total yearly compensation is £5.81M, comprised of 18.9% salary and 81.1% bonuses, including company stock and options. directly owns 0.006% of the company’s shares, worth €2.55M. The average tenure of the management team and the board of directors is 1.6 years and 2.4 years respectively.
Key information
Kris Licht
Chief executive officer
UK£5.8m
Total compensation
| CEO salary percentage | 18.9% |
| CEO tenure | 1.6yrs |
| CEO ownership | 0.006% |
| Management average tenure | 1.6yrs |
| Board average tenure | 2.4yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2024 | UK£6m | UK£1m | UK£1b |
| Jun 30 2024 | n/a | n/a | UK£2b |
| Mar 31 2024 | n/a | n/a | UK£2b |
| Dec 31 2023 | UK£3m | UK£575k | UK£2b |
Compensation vs Market: Kris's total compensation ($USD7.72M) is above average for companies of similar size in the German market ($USD5.27M).
Compensation vs Earnings: Kris's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
CEO
Kris Licht (48 yo)
1.6yrs
Tenure
UK£5,807,092
Compensation
Mr. Kristoffer Loe Licht, also known as Kris, had been President of Health and Chief Customer Officer at Reckitt Benckiser Group plc since July 1, 2020 until October 01, 2023 and serves as its Chief Execut...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 1.6yrs | UK£5.81m | 0.0064% € 2.5m | |
| CFO & Executive Director | 1.2yrs | UK£3.01m | 0.00045% € 178.9k | |
| Head of Investor Relations | no data | no data | no data | |
| Senior VP | 3.3yrs | no data | no data | |
| Chief Human Resources Officer | 5.2yrs | no data | no data | |
| President North America | less than a year | no data | no data | |
| Chief Research & Development Officer | 4.7yrs | no data | no data | |
| President of Health | 3.8yrs | no data | no data | |
| President of Nutrition | 1.8yrs | no data | no data | |
| Chief Science & Medical Officer of Mead Johnson Nutrition (MJN) Business | less than a year | no data | no data | |
| Chief Category Growth Officer | less than a year | no data | no data | |
| Chief Supply Officer | less than a year | no data | no data |
1.6yrs
Average Tenure
50yo
Average Age
Experienced Management: 3RB's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 1.9yrs | UK£5.81m | 0.0064% € 2.5m | |
| CFO & Executive Director | 1.6yrs | UK£3.01m | 0.00045% € 178.9k | |
| Senior Independent Non-Executive Director | 6.8yrs | UK£168.33k | 0.00021% € 83.5k | |
| Independent Non-Executive Director | 2.3yrs | UK£130.00k | 0.000080% € 31.8k | |
| Independent Non-Executive Chairman | 2.5yrs | UK£508.33k | 0.00024% € 95.4k | |
| Independent Non-Executive Director | less than a year | UK£73.54k | 0.000040% € 15.9k | |
| Independent Non-Executive Director | 6.8yrs | UK£140.00k | 0.00021% € 83.5k | |
| Independent Non-Executive Director | 10.3yrs | UK£146.67k | 0.00053% € 210.7k | |
| Independent Non-Executive Director | 4.8yrs | UK£130.00k | 0.00016% € 63.6k | |
| Independent Non-Executive Director | 6.7yrs | UK£143.33k | 0.00069% € 274.3k | |
| Independent Non-Executive Director | less than a year | no data | no data | |
| Independent Non-Executive Director | 1.3yrs | UK£128.22k | 0.0011% € 421.4k |
2.4yrs
Average Tenure
59.5yo
Average Age
Experienced Board: 3RB's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/05 10:41 |
| End of Day Share Price | 2025/05/02 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Reckitt Benckiser Group plc is covered by 54 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Pedro Gil Garcia Alejo | Banco Santander |
| Susanne Seibel | Barclays |
| Iain Simpson | Barclays |